Processa Pharmaceuticals, Inc.
For the period ended Dec 31, 2025. Filed Mar 18, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 18, 2026
PCSA$1.95+1.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
We maintain our principal executive office at 601 21 st Street, Suite 300 Vero Beach, FL 32960 pursuant to a virtual office agreement.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.